...
ONCOMICRO

Onconetix, Inc.

HealthcareBiotechnology
$0.67
$0.00(+1.36%)
52W$0.62
$25.50
Updated Mar 1, 12:00 AM
RSI34
RS Rating2/99
Beta1.22
Volatility129%
F-Score3/9
Mkt Cap$8M
DOWNTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

DOWNTREND

Onconetix, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 2), showing significant lag compared to the market leaders. Earnings contraction of 113% provides fundamental context to the price action. Investors should exercise caution due to high volatility (129% annualized), which requires wider risk management.

Relative Strength
2
out of 99
Lagging
Trend Score
0/4
Minervini Criteria
DOWNTREND
Risk (Beta)
1.22
vs S&P 500
ABOVE MKT
52W Position
0%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

DOWNTREND0/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$1.38
50 SMA > 100 SMA$2.17
100 SMA > 150 SMA$2.46
150 SMA > 200 SMA$3.16

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$1.04-35.77%BELOW
50 SMA$1.38-51.66%BELOW
100 SMA$2.17-69.14%BELOW
150 SMA$2.46-72.80%BELOW
200 SMA$3.16-78.84%BELOW

Price Performance

1D+1.4%
1W+0.8%
1M-55.4%
3M-75.9%
6M-77.7%
YTD-58.4%
1Y-96.8%
3Y-94.5%
52-Week Trading Range0% from low
$0.67
52W Low$0.62
52W High$25.50

Technical Indicators

RSI (14)BEARISH
33.5
305070
VCP ScoreCOOL
3/10
Base depth: 388.0%

Risk Profile

Beta
1.22
52W Vol
129%
ATR
$0.20
Max DD (1Y)
-97%

Volume Analysis

Today
50D Avg
246.2K
Vol Ratio
0.00x
Liquidity
ILLIQUID

Earnings Momentum

Q4'24-1638%
$-17.38
Q1'25-360300%
$-1802.00
Q2'25-644%
$-4.76
Q3'25-113%
$-6.25
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:-34.58%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-360.02%

Stock Price CAGR

10 Years:-71.59%
5 Years:-91.93%
3 Years:-94.48%
1 Year:-96.82%

Return on Equity

10Y Avg:-274.5%
5Y Avg:-326.6%
3Y Avg:-497.6%
Last Year:-1456.4%

Key Metrics

Market Cap$8M
Gross Margin41.8%
Net Margin-23.3%
Piotroski F-Score3/9

Frequently Asked Questions

Is ONCO in an uptrend right now?

ONCO has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.

Is ONCO overbought or oversold?

ONCO's RSI (14) is 34. The stock is in neutral territory, neither overbought nor oversold.

Is ONCO outperforming the market?

ONCO has a Relative Strength (RS) Rating of 2 out of 99. ONCO is currently lagging the broader market.

Where is ONCO in its 52-week range?

ONCO is trading at $0.67, which is 3% of its 52-week high ($25.50) and 0% above its 52-week low ($0.62).

How volatile is ONCO?

ONCO has a Beta of 1.22 and 52-week volatility of 129%. It's more volatile than the S&P 500 - expect bigger swings.